Your browser doesn't support javascript.
loading
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection.
Brennick, Cory A; George, Mariam M; Moussa, Marmar M; Hagymasi, Adam T; Seesi, Sahar Al; Shcheglova, Tatiana V; Englander, Ryan P; Keller, Grant Lj; Balsbaugh, Jeremy L; Baker, Brian M; Schietinger, Andrea; Mandoiu, Ion I; Srivastava, Pramod K.
Afiliação
  • Brennick CA; Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • George MM; Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Moussa MM; Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Hagymasi AT; Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Seesi SA; Computer Science Department, Smith College, Northampton, Massachusetts, USA.
  • Shcheglova TV; Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Englander RP; Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Keller GL; Department of Chemistry and Biochemistry and Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
  • Balsbaugh JL; Proteomics and Metabolomics Facility, Center for Open Research Resources and Equipment, University of Connecticut, Storrs, Connecticut, USA.
  • Baker BM; Department of Chemistry and Biochemistry and Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
  • Schietinger A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Mandoiu II; Weill Cornell Medical College, Cornell University, New York, New York, USA.
  • Srivastava PK; Department of Computer Science and Engineering, University of Connecticut, Storrs, Connecticut, USA.
J Clin Invest ; 131(3)2021 02 01.
Article em En | MEDLINE | ID: mdl-33320837
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Epitopos de Linfócito T / Vacinas Anticâncer / Imunoterapia / Antígenos de Neoplasias / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Epitopos de Linfócito T / Vacinas Anticâncer / Imunoterapia / Antígenos de Neoplasias / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos